Meconium Ileus Clinical Trial
Official title:
The Impact of Visceral Osteopathic Treatment on the Meconium Evacuation in Very Low Birth Weight Infants
Verified date | May 2014 |
Source | Medical University of Vienna |
Contact | n/a |
Is FDA regulated | No |
Health authority | Austria: Medical University of Vienna |
Study type | Interventional |
Timing of the first and last meconium stool is critical for oral feeding tolerance and proper gastrointestinal function. The time until premature infants pass their first meconium ranges from 1 hour to 27 days (median: 43 hours). Obstruction of the gastrointestinal tract by tenacious, sticky meconium frequently leads to gastric residuals, a distended abdomen and delayed food passage Recent data support the concept that complete rapid evacuation of meconium plays a key role in feeding tolerance . If duration to full enteral feedings is extended, the probability to acquire infections due to intravenous access for parenteral nutrition increases and hospital stay of the infant prolongates. Previously two prospective trials focusing on the problem of delayed meconium evacuation in preterm with different therapeutic pharmacological approaches were published by our group. None of the applied therapies appeared to be effective or had a beneficial effect- quite the contrary one agent (Gastrografin) was supposed to have severe negative side effects. Therefore we were looking for an alternative, non-invasive, holistic solution for the problem of delayed meconium excretion. Osteopathic treatment with the emphasis on the relationship of the structural and functional integrity of the body and with its variety of therapeutic manual techniques seemed to be remedy. Treating the abdomen of premature infants with visceral osteopathic techniques might be more effective to mobilize meconium from small bowel and deep parts of the colon. Therefore we hypothesized that repeated visceral osteopathic treatment accelerates meconium evacuation in premature infants, and thereby enhances feeding tolerance in this population.
Status | Completed |
Enrollment | 41 |
Est. completion date | February 2012 |
Est. primary completion date | February 2012 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | N/A to 24 Hours |
Eligibility |
Inclusion Criteria: - premature infants with a birthweight 1500 gram Exclusion Criteria: - major congenital malformations - known gastrointestinal abnormalities |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Austria | Nadja Haiden | Vienna |
Lead Sponsor | Collaborator |
---|---|
Medical University of Vienna |
Austria,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | complete meconium evacuation | Primary outcome parameter was specified as complete meconium excretion. The time to complete meconium evacuation was defined as day of life on which the last meconium was passed. The nursing staff assessed the quality of stools as "meconium" (black, thick, sticky) or "non meconium" by appearance and documented data into the electronic patient documentation system. | days up to 100 days of life | No |
Secondary | Time to full enteral feedings | days up to 100 days of life | Yes | |
Secondary | Introduction of enteral feedings | days up to 100 days of life | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01515696 -
Impact of Oral Application of Gastrografin on the Meconium Evacuation in Very Low Birth Weight Infants
|
Phase 4 | |
Completed |
NCT04020939 -
The Role of Indocyanine Green Angiography Fluorescence on Intestinal Resections in Pediatric Surgery.
|
N/A | |
Recruiting |
NCT05293353 -
Neokare Safety and Tolerability Assessment in Neonates With GI Problems
|
||
Not yet recruiting |
NCT03593252 -
Bowel Preparation in Elective Pediatric Colorectal Surgery
|
N/A | |
Completed |
NCT04713579 -
Timing of Stoma Closure in Neonates
|
||
Terminated |
NCT02710383 -
Biomarker for Cystic Fibrosis
|